DNMT1 and colonic neoplasm: Most recently, the flavonolignan silibinin, which is the main pharmacologically active component of the milk thistle plant (Silybum marianum) with anti-cancer properties is able to significantly inhibit DNMT activity in colon cancer cells (159).